BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 6842393)

  • 1. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metal cations and calmodulin antagonists on [3H] nitrendipine binding in smooth and cardiac muscle.
    Luchowski EM; Yousif F; Triggle DJ; Maurer SC; Sarmiento JG; Janis RA
    J Pharmacol Exp Ther; 1984 Sep; 230(3):607-13. PubMed ID: 6433001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
    Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
    Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
    Wei XY; Luchowski EM; Rutledge A; Su CM; Triggle DJ
    J Pharmacol Exp Ther; 1986 Oct; 239(1):144-53. PubMed ID: 2428971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle.
    Miller WC; Moore JB
    Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel.
    Fairhurst AS; Thayer SA; Colker JE; Beatty DA
    Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
    Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
    Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
    Bellemann P; Ferry D; Lübbecke F; Glossman H
    Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
    Balwierczak JL; Grupp IL; Grupp G; Schwartz A
    J Pharmacol Exp Ther; 1986 Apr; 237(1):40-8. PubMed ID: 2937911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unitary mechanism of calcium antagonist drug action.
    Murphy KM; Gould RJ; Largent BL; Snyder SH
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):860-4. PubMed ID: 6572372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists. Some chemical-pharmacologic aspects.
    Triggle DJ; Swamy VC
    Circ Res; 1983 Feb; 52(2 Pt 2):I17-28. PubMed ID: 6299605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
    Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
    Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
    Schoemaker H; Boles RG; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.